Medisca opens MAZ® Lab in Arizona: a center of innovation and resources for customers
PLATTSBURGH, N.Y.–(BUSINESS WIRE)–Medisca, a global leader in personalized medicine and pharmaceutical supply chain solutions, is proud to announce the opening of the Medisca MAZ Lab in Phoenix, Arizona. Dedicated exclusively to the development and expansion of the MAZ ecosystem, the MAZ Lab is a center for innovation and customer resources.
Introduced in 2016 as the first planetary mixer to enter the pharmaceutical formulation market and now making its mark in the cannabis and other wellness industries, MAZ technology has redefined how personalized medicine and consumer goods are manufactured, thereby addressing gaps in production processes and setting a new standard for precision, versatility, and efficiency.
«Building on more than 10 years of research and development, proprietary operating procedures, more than 200 formulations, and more than eight patents, we are thrilled to begin our next chapter of innovation and expansion with the opening of the MAZ Lab,» said Panagiota Danopoulos, senior vice president of global strategy and innovation at Medisca. «Serving as research, exploration, testing, and development center, the MAZ Lab provides an infrastructure for growth and opportunities while creating a space to connect with and train our valued partners »and customers."
As evidence of the company’s commitment to addressing gaps in healthcare, the Medisca MAZ Lab will support ongoing efforts to develop intellectual property and customized testing solutions for clients, with the goal of enabling professionals across various wellness sectors to precisely design, efficiently produce, and provide access to unique consumer products.
To learn more about how Medisca protects the intellectual property of MAZ technology, click here.
About Medisca
Founded in 1989, Medisca is a global leader in personalized medicine and pharmaceutical supply chain solutions, with an extensive portfolio of more than 2,000 products, complemented by a library of more than 10,000 personalized medication formulations, expertise and services in pharmaceutical compounding, continuing education in healthcare, analytical testing, and more. By providing finely tailored solutions to various wellness sectors around the world, Medisca bridges gaps in healthcare and promotes personalized well-being for all. For more information, visit www.medisca.com and follow us on LinkedIn , Facebook and YouTube .
The text of the press release resulting from a translation must in no way be considered as official. The only authentic version of the press release is the one in its original language. The translation must always be compared with the source text, which will be the legal precedent.
Contact
Adam Pinsky
Head of Communications at Medisca
[email protected]
-
Business2 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France4 weeks ago
Which countries legalized medical cannabis before France?
-
Business4 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in France4 days ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Thailand4 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis in the U.S.5 days ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in France3 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts



